| You are currently viewing our forum as a guest. This means you are limited to certain areas of the board and that there are some features you can't use or read. We are an active community of worldwide senior members participating in chat, politics, travel, health, blogging, graphics, computer issues & help, book club, literature & poetry, finance discussions, recipe exchange and much more. Also, as a member you will be able to access member only sections, many features, send personal messages, make new friends, etc. Registration is simple, fast and completely free. Why not register today and become a part of the group. Registration button at the very top left of the page. Thank you for stopping by. Join our community! In case of difficulty, email worldwideseniors.org@gmail.com. If you're already a member please log in to your account to access all of our features: |
| India's top court rejects Novartis cancer drug patent bid | |
|---|---|
| Topic Started: Apr 2 2013, 01:16 AM (116 Views) | |
| Darcie | Apr 2 2013, 01:16 AM Post #1 |
|
Skeptic
|
http://www.cbc.ca/news/world/story/2013/04/01/india-novartis-cancer-drugs-patents.html A great big bouquet to India's top court. India's Supreme Court today rejected drugmaker Novartis AG's attempt to patent a new version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. Novartis had argued that it needed a patent to protect its investment in the cancer drug Glivec, while activists said the company was trying to use a loophole to make more money out of a drug that did not have a patent. The decision has global significance since India's generic drug industry, pegged to be valued at $26 billion US, supplies much of the cheap medicine used in the developing world. Pratibha Singh, a lawyer for the Indian generic drug manufacturer Cipla, which makes a version of Glivec for less than a tenth of the original drug's selling price, said the ruling sets a precedent that will prevent international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs. The court ruled that a patent could only be given to a new drug, she told reporters outside the court.
|
|
|
|
| 1 user reading this topic (1 Guest and 0 Anonymous) | |
| « Previous Topic · Rants, Bouquets, Consumer Issues · Next Topic » |